At Tris Pharma, we’re on a mission to uniquely solve some of the most intractable therapeutic challenges in ADHD, pain, addiction and other diseases of the central nervous system Learn MoreBREAKING NEWS Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol...
Products Tris Pharma offers stimulant and non-stimulant treatment options for pediatric and adult patients with ADHD.ADHD Innovation Unique, consistent drug delivery1 Discover our advanced technology to fit your patients' unique needs.Stimulant ADHD Treatments For patients 6 years and older with ADHD ....
At Tris Pharma, we embrace the unique backgrounds and authentic selves of the individuals whose contributions make our organization exceptional to create an inclusive and representative community. Our commitment to a respectable and culturally diverse work environment is among the company’s most ...
DYANAVEL andLiquiXR®are registered trademarks of Tris Pharma, Inc. Quillivant XR and QuilliChew ER are registered trademarks of NextWave Pharmaceuticals, Inc. NextWave Pharmaceuticals, Inc. is a wholly owned subsidiary of Tris Pharma, Inc....
Check out resources from Tris Pharma, including savings on Tris products, guides for parents, our Find a Pharmacy tool, ADHD community resources, and more
Sign up to receive more information about Tris Pharma and the Tris family of products.I am a Patient Caregiver Important Safety Information & Approved Use DYANAVEL® XR (amphetamine), Quillivant XR® (methylphenidate HCI), and QuilliChew ER® (methylphenidate HCI) are federally controlled ...
Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD –Tris Digital Health enters into licensing agreement with Braingaze to develop and commercialize first-in-class, AI-enhanced technology that offers healthcare professionals an objective to...
To report SUSPECTED ADVERSE REACTIONS, contact Tris Pharma, Inc. at (732) 940-0358 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatch. Please seeFull Prescribing Informationfor QuilliChew ER, including Boxed Warning regarding Abuse, Misuse, and Addiction....
Discover three different ADHD medication options from Tris Pharma to help treat ADHD symptoms experienced by you or your child with ADHD ages 6 or older
To report SUSPECTED ADVERSE REACTIONS, contact Tris Pharma, Inc. at (732) 940-0358 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatch. Please seeFull Prescribing Informationfor QuilliChew ER, including Boxed Warning regarding Abuse, Misuse, and Addiction....